Csenge Advisory Group Clene Inc. Transaction History
Csenge Advisory Group
- $1.97 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding CLNN
# of Institutions
6Shares Held
230KCall Options Held
0Put Options Held
25K-
Morgan Jess S & CO Inc112KShares$461,4400.27% of portfolio
-
Black Rock Inc. New York, NY83.5KShares$343,8180.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ25.2KShares$103,9470.0% of portfolio
-
Jefferies Group LLC New York, NY4.96KShares$20,4180.0% of portfolio
-
Cutler Group LP3.9KShares$16,0680.0% of portfolio
About Clene Inc.
- Ticker CLNN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,502,000
- Market Cap $262M
- Description
- Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...